Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma

6 Nov 2023

Abstract excerpt

Glioma is a common intracranial tumor and is generally associated with poor prognosis. Recently, numerous studies illustrated the importance of 5-methylcytosine (m5C) RNA modification to tumorigenesis. However, the prognostic value and immune correlation of m5C in glioma remain unclear. We obtained RNA expression and clinical information from The Cancer Genome Atlas (TCGA) and The Chinese Glioma Genome Atlas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37934565
DOI: 10.18632/aging.205179

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in gliomaPMID 37934565Read ↗

Integrated analysis from multicentre studies identities RNA methylation- related lncRNA risk stratification systems for gliomaSemantic proximity Read ↗

Molecular and clinical characterization of 5mC regulators in glioma: results of a multicenter studySemantic proximity Read ↗

Comprehensive analysis of m6A/m5C/m1A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in gliomaSemantic proximity Read ↗

An m1A/m6A/m7G/m5C regulator-mediated methylation modification pattern and Landscape of immune microenvironment infiltration characterization in Lower-Grade Glioma cohorts from three continents based on machine learningSemantic proximity Read ↗

A bioinformatic analysis study of m7G regulator-mediated methylation modification patterns and tumor microenvironment infiltration in glioblastomaSemantic proximity Read ↗

Clinicopathological signature and prognostic value of RNA:m5C methyltransferases in gliomasSemantic proximity Read ↗

m6A function and tumor microenvironment infiltration characteristics in gliomaSemantic proximity Read ↗

Identification of N6-Methyladenosine-Related Gene Based Prognostic Signature to Predict Survival and Potential Therapeutic Drugs in GliomaSemantic proximity Read ↗

Identification of m6A methyltransferase-related WTAP and ZC3H13 predicts immune infiltrates in glioblastomaSemantic proximity Read ↗

Uncovering N7-Methylguanosine regulator-mediated methylation modification pattern and Landscape of anti-PD-1/L1 Immunotherapy and immune microenvironment infiltration characterization in Lower-Grade GliomaSemantic proximity Read ↗

The Prognostic Value and Immune Landscaps of m6A/m5C-related LncRNAs signature in the Low Grade GliomaSemantic proximity Read ↗

m1A RNA Methylation Regulators Contribute To Malignant Progression And Have Clinical Prognostic Impact In GliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.